8.00% p.a. Early Redemption Kick-In GOAL
Basiswert: Bayer / Novartis / Roche / Vertex Pharmaceuticals SVSP/EUSIPA Produkttyp: Barrier Reverse Convertibles (1230, Auto-Callable) SIX Symbol: KACPAU / Valor: 37559007 / ISIN: CH0375590079
-
Geld
95.05 %
Volumen: 100'000 -
Brief
96.05 %
Volumen: 100'000
Strike | 100.00% |
Early Redemption Level | 100.00% |
Währung | CHF |
Emittentin | UBS AG, London Branch |
Rückzahlung | bar |
Emissionsdatum | 28.07.2017 |
Verfall | 15.02.2019 |
Handelsplatz | SIX SP Exchange |
Barriere | 59.00% |
Barriere berührt | Nein |
Seitwärtsrendite | 10.83% / 13.09% p.a. |
Basiswert Preis1) Bayer Novartis Roche Vertex Pharmaceuticals | 97.37 EUR 75.36 CHF 217.70 CHF 155.15 USD |
Barrieremonitor
Name | Bayer |
Preis1) | 97.37 EUR |
Barriereabstand | 34.50% |
Absolute Barriere | 63.779 EUR |
Name | Roche |
Preis1) | 217.70 CHF |
Barriereabstand | 33.57% |
Absolute Barriere | 144.609 CHF |
Worst Performer |
Name | Vertex Pharmaceuticals |
Preis1) | 155.15 USD |
Barriereabstand | 42.44% |
Absolute Barriere | 89.3083 USD |
Name | Novartis |
Preis1) | 75.36 CHF |
Barriereabstand | 35.84% |
Absolute Barriere | 48.3505 CHF |